[en] Degenerative osteoarthropathy resulting in a reduced active lifespan was observed in Ardenner horses. In the context of joint biology, insulin-like growth factor I (IGF-I) is a potential candidate to affect the anabolism of cartilage matrix molecules. A group of 30 Ardenner horses reared under standardized conditions from weaning were evaluated periodically from 15 to 28 months of age to detect the early manifestations of the disease. At the end of this period, horses were classified in two pathological groups related to the degree of interphalangeal degenerative osteoarthropathy based on clinical and radiographic evaluations: healthy (46.7%) and pathological (53.3%) horses. Seven sequential blood samples were taken from each horse (during the evaluation period) to study the variation of IGF-I plasma concentration. We tested the variations of the IGF-I plasma concentration during growth, and the effect of sex and of pathological classes. Significant variations were observed during the research period, with a maximum value corresponding to spring and a minimum in autumn. A significant reduction of the IGF-I plasma concentration was also observed in the pathological horses (433.5 +/- 19.5 ng/ml) compared to the healthy horses (493.9 +/- 18.2 ng/ml). An alteration in the level of this growth factor could induce a disregulation of the mechanisms involved in the local control of joint and bone tissue development.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Lejeune, Jean-Philippe ; Université de Liège - ULiège et Centre européen du cheval de Mont-le-Soie > Département clinique des animaux de compagnie et des équidés > Anesthésiologie gén. et pathologie chirurg. des grds animaux
Franck, Thierry ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Anesthésiologie gén. et pathologie chirurg. des grds animaux
Michaux, Charles ; Université de Liège - ULiège > Département de productions animales > Biostatistique, économie, sélection animale
Deby-Dupont, Ginette
Serteyn, Didier ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Anesthésiologie gén. et pathologie chirurg. des grds animaux
Language :
English
Title :
Plasma concentration of insulin-like growth factor I (IGF-I) in growing Ardenner horses suffering from juvenile digital degenerative osteoarthropathy
American Association of Equine Practitioners, 1999. Guide to veterinary services for horse shows, ed 7, Lexington, Ky
Caudron, I., 1997. Approche orthopédique des affections ostéo-articulaires dégénératives de l'extrémité digitate du cheval. Prevention et traitement, (PhD thesis). University ofde Lige
Champion, Z.J., Breier, B.H., Ewen, W.E., Tobin, T.T. and Casey, P.J., 2002. Blood plasma concentrations of insulin-like growth factor-I (IGF-I) in resting standardbred horses. Veterinary Journal, 163, 45-50
Chlebna-Sokol, D. and Rusinska, A., 2001. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis. Endocrine Regulations, 35, 201-208
Christensen, R.A., Malinowski, K., Massenzio, A.M., Hafs, H.D. and Scanes, C.G., 1997. Acute effects of short-term feed deprivation and refeeding on circulating concentrations of metabolites, insulin-like growth factor I, insulin-like growth factor binding proteins, somatotropin, and thyroid hormones in adult geldings. Journal of Animal Science, 75, 1351-1358
Dart, A.J., Little, C.B., Hugues, C.E., Chu, O., Dowling, B.A., Hodgson, D.R., Rose, R.J. and Johnson, K.A. 2003. Recombinant equine growth hormone administration: Effects on synovial fluid biomarkers and cartilage metabolism in horses. Equine Veterinary Journal, 35, 302-307
Daughaday, W.H. and Rotwein, P., 1989. Insulin-like growth factors I and II: Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocrine Reviews, 10, 68-69
Dubaquie, Y., Mortensen, D.L., Intintoli, A., Hogue, D.H., Nakamura, G., Rancatore, P., Lester, P., Sadick, M.D., Filvaroff, E., Fielder, P.J. and Lowman, H.B., 2001. Binding protein-3-selective insulin-like growth factor I variants: Engineering, biodistributions, and clearance. Endocrinology, 142, 165-173
Fortier, L.A., Mohammed, H.O., Lust, G. and Nixon, A.J., 2002a. Insulin-like growth factor-I enhances cell-based repair of articular cartilage. Journal of Bone and Joint Surgery, British Volume, 84, 276-288
Fortier, L.A., Nixon, A.J. and Lust, G., 2002b. Phenotypic expression of equine articular chondrocytes grown in three-dimensional cultures supplemented with supraphysiologic concentrations of insulin-like growth factor-1. American Journal of Veterinary Research, 63, 301-305
Fortier, L.A., Deak, M.M., Semevolos, S.A. and Cerione, R.A., 2004. Insulin-like growth factor-I diminishes the activation status and expression of the small GTPase Cdc42 in articular chondrocytes. Journal of Orthopaedic Research, 22, 436-445
Fortier, L.A., Kornatowski, M.A., Mohammed, H.O., Jordan, M.T., O'Cain, L.C. and Stevens, W.B., 2005. Age-related changes in serum insulin-like growth factor-1, insulin-like growth factor-1 binding protein-3 and articular structure in thoughbred horses. Equine Veterinary Journal, 37, 37-42
Fosang, A.J., Tyler, J.A. and Hardingham, T.E., 1991. Effect of interleukin-1 and insulin like growth factor-1 on the release of proteoglycan components and hyaluronan from pig articular cartilage in explant culture. Matrix, 11, 17-24
Frisbie, D.D., Ghivizzani, S.C. and Robbins, P.D., 2002. Treatment of experimental equine osteoarthritis by in vivo delivery of equine interleukin-1 receptor antagonist gene. Gene Therapy, 9, 12-20
Haupt, J.L., Frisbie, D.D., Mcllwraith, C.W., Robbins, P.D., Ghivizzani, S., Evans, C.H. and Nixon, A.J., 2005. Dual transduction of insulin-like growth factor-I and interleukin-1 receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model. Journal of Orthopaedic Research, 23, 118-126
Hui, W., Rowan, A.D. and Cawston, T., 2001. Modulation of the expression of matrix metalloproteinase and tissue inhibitors of metalloproteinases by TGF-betal and IGF-1 in primary human articular and bovine nasal chondrocytes stimulated with TNF-alpha. Cytokine, 16, 31-35
Jackson, B.F., Goodship, A.E., Eastell, R. and Price, J.S., 2003a. Evaluation of serum concentrations of biochemical markers of bone metabolism and insulin-like growth factor I associated with treadmill exercise in young horses. American Journal of Veterinary Research, 64, 1549-1556
Jackson, B.F., Blumsohn, A., Goodship, A.E., Wilson, A.M. and Rice, J.S., 2003b. Circadian variation in biochemical markers of bone cell activity and insulin-like growth factor-I in two-year-old horses. Journal of Animal Science, 81, 2804-2810
Lejeune, J.P., Schneider, N., Duvivier, D.H., Michaux, C., Caudron, I. and Serteyn, D., 2002. Arthropathie inter-phalangienne dégénérative juvénile chez le cheval ardennais: Protocole d'évaluation radiographique (Partie II). Annales de Médecine Vétérinaire 146, 173-179
Lo, M.Y. and Kim, H.T., 2004. Chondrocyte apoptosis induced by collagen degradation: Inhibition by caspase inhibitors and IGF-1. Journal of Orthopaedic Research, 22, 140-144
Luyten, P.P., Hascall, V.C., Nissley, S.P., Morales, T.I. and Reddi, A.H., 1988. Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular expiants. Archives of Biochemistry and Biophysics, 267, 416-425
McPherson, M.L., Simmen, R.C., Simmen, P.A., Hernandez, J., Sheerin, B.R., Vamer, D.D., Loomis, P., Cadario, M.E., Miller, C.D., Brinsko, S.P., Rigby, S. and Blanchard, T.L., 2002. Insulin-like growth factor-I and insulin-like growth factor binding protein-2 and -5 in equine seminal plasma: Association with sperm characteristics and fertility. Biology of Reproduction, 67, 648-654
Malinowski, K., Christensen, R.A., Hafs, H.D. and Scanes, C.G., 1996. Age and breed differences in thyroid hormones, insulin-like growth factor (IGF)-I and IGF binding proteins in female horses. Journal of Animal Science, 74, 1936-1942
Martel-Pelletier, J., 1998. Pathophysiology of osteoarthritis. Osteoarthritis Cartilage, 6, 374-376
Melo, M.I., Sereno, J.R., Henry, M. and Cassali, G.D., 1998. Peripuberal sexual development of Pantaneiro stallions. Theriogeneology, 50, 727-737
Naden, J., Amann, R.P. and Squires, E.L., 1990a. Testicular growth, hormone concentrations, seminal characteristics and sexual behaviour in stallions. Journal of Reproduction and Fertility, 88, 167-176
Naden, J., Squires, E.L. and Nett, T.M., 1990b. Effect of maternal treatment with altrenogest on age at puberty, hormone concentrations, pituitary response to exogenous GnRH, oestrous cycle characteristics and fertility of fillies. Journal of Reproduction and Fertility, 88, 185-195
Nixon, A.J., Saxer, R.A. and Brower-Toland, B.D., 2001. Exogenous insulin-like growth factor-I stimulates an autoinductive IGF-I autocrine/ paracrine response in chondrocytes. Journal of Orthopaedic Research, 19, 26-32
Oh, C.D. and Chun, J.S., 2003. Signaling mechanisms leading to the regulation of differentiation and apoptosis of articular chondrocytes by insulin-like growth factor-1. Journal of Biological Chemistry, 278, 36563-36571
Popot, M.A., Bobin, S., Bonnaire, Y., Pirens, G., Closset, J., Delahaut, P. and Tabet, J.C., 2001. High performance liquid chromatography-ion trap mass spectrometry for the determination of insulin-like growth factor-1 in horse plasma. Chromatogmphia, 54, 737-741
Prosser, C.G. and McLaren, R.D., 1992. Insulin-like growth factor binding proteins of equine serum. Biochemical and Biophysical Research Communications, 189, 1255-1260
Robert, C., Denoix, J.M. and Houliez, D., 1995. Evolution des images radiologiques des articulations des membres de chevaux entre 3 et 6 ans: résultats préliminaires sur 46 sujets. Pratique Vétérinaire Equine, 27, 143-152
Ropp, J.K., Raub, R.H. and Minton, J.E., 2003. The effect of dietary energy source on serum concentration of insulin-like growth factor-I growth hormone, insulin, glucose, and fat metabolites in weanling horses. Journal of Animal Science, 81, 1581-1589
Sloet van Oldruitenborgh-Ooste, Mol, J.A. and Barneveld, A. 1999. Hormones, growth factors and other plasma variables in relation to osteochondrosis. Equine Veterinary Journal Supplement, 31, 45-54
Sticker, L.S., Thompson, D.L. Jr., Bunting L.D., Fernandez, J.M., DePew, C.L. and Nadal, M.R., 1995a. Feed deprivation of mares: Plasma metabolite and hormonal concentrations and responses to exercise. Journal of Animal Science, 73, 3696-3704
Sticker, L.S., Thompson, D.L. Jr., Fernandez, J. M., Bunting, L. D. and DePew, C. L., 1995b. Dietary protein and(or) energy restriction in mares: Plasma growth hormone, IGF-I, prolactin, cortisol, and thyroid hormone responses to feeding, glucose, and epinephrine. Journal of Animal Science, 73, 1424-1432
Studer, R.K., Levicoff, E., Georgescu, H., Miller, L., Jaffurs, D., and Evans C.H., 2000. Nitric oxide inhibits chondrocyte response to IGF-I: inhibition of IGF-IR tyrosine phosphorylation American Journal of Physiology. Cell Physiology, 279, 961-969
Studer, R.K., Decker, K., Melhem, S. and Georgescu, H., 2003. Nitric oxide inhibition of IGF-1 stimulated proteoglycan synthesis: Role of cGMP. Journal of Orthopaedic Research, 21, 914-921
Van der Eerden, B.C., Karperien M., and Wit, J.M., 2003. Systemic and local regulation of the growth plate. Endocrine Reviews, 24, 782-801
Van der Kraan, P.M., Buma, P., Van Kuppevelt, T. and Van den Berg, W.B., 2002. Interaction of chondrocytes, extracellular matrix and growth factors: Relevance for articular cartilage tissue engineering. Osteoarthritis and Cartilage, 10, 631-637
Zofkova, I., 2003. Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism. Physiological Research, 52, 657-679
